The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

Leqselvi (deuruxolitinib) 8 mg tablets are approved for adults with severe alopecia areata, a disease that causes the immune system to attack hair follicles, leading to partial or complete hair loss ...

A participant before (left) and after (right) week 24 of the trial. Alopecia areata first makes itself know through patches of coin-sized hair loss - usually round or oval - on the scalp, as well ...

LEQSELVI has shown rapid results in clinical trials, with one-third of patients regaining nearly full scalp hair by Week 24.

How severe it is depends on the percentage of the scalp with hair loss. Mild alopecia areata ranges from 0% to 20%, moderate is from 21% to 49%, and severe is from 50% to 100%.

Round or oval patches of hair loss on the scalp, face, or body; Tingling, itching, or burning in the affected areas, either before or after hair loss; Nail changes, including ridges or pitting (dents) ...

However, because this is a chronic condition that can occur in cycles, future episodes of hair loss are possible. The causes of alopecia areata are not yet fully understood.

It may start as patchy alopecia areata, then develop into alopecia totalis within 6 months after hair loss was recognized. If you have alopecia universalis, you have hair loss on your whole body.

Update, July 11, 2025: We checked all product prices and availability. Our picks for the best hair growth products remain ...

For patients with severe alopecia areata who had meaningful hair regrowth after 1 year of oral baricitinib (Olumiant) therapy, treatment withdrawal resulted in loss of benefit in almost all ...